This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Currax Pharmaceuticals LLC, Pernix Sleep, Inc.. Active years: 2015-2022.
Company Filing History:
Years Active: 2015-2022
Title: Innovations in Sleep Treatment by Susan Ellen Dube
Introduction
Susan Ellen Dube is a notable inventor based in Carlsbad, California. She has made significant contributions to the field of sleep medicine, particularly focusing on the treatment of sleep disorders in elderly patients. With two patents to her name, her work has the potential to improve the quality of life for many individuals suffering from insomnia and related conditions.
Latest Patents
Dube's latest patents include innovative methods for treating sleep disorders, specifically targeting elderly patients aged 65 years and older. One of her key inventions is a method involving low-dose doxepin, which is administered in initial daily dosages of 1-3 mg. This approach has been shown to be more effective in reducing wake time during sleep, latency to persistent sleep, and wake time after sleep compared to non-elderly patients. Additionally, these ultra-low dosages are deemed safe for elderly individuals. Another patent focuses on preventing early awakenings and improving sleep efficiency during the last hours of sleep by administering low doses of doxepin, ranging from 1-6 mg.
Career Highlights
Throughout her career, Dube has worked with prominent companies in the pharmaceutical industry, including Pernix Sleep, Inc. and Currax Pharmaceuticals LLC. Her experience in these organizations has allowed her to develop and refine her innovative approaches to sleep treatment.
Collaborations
Dube has collaborated with several professionals in her field, including Roberta L. Rogowski and Philip Jochelson. These partnerships have contributed to her research and the development of her patents.
Conclusion
Susan Ellen Dube's work in the realm of sleep medicine showcases her dedication to improving the lives of elderly patients suffering from sleep disorders. Her innovative methods and patents reflect her commitment to advancing treatment options in this important area of healthcare.